NYSE: DCODucommun Inc Stock
$68.26+1.28 (+1.91%)
Updated Jan 15, 2025
DCO Price
$68.26
Fair Value Price
N/A
Market Cap
$1.01B
52 Week Low
$47.53
52 Week High
$70.50
P/E
33.63x
P/B
1.52x
P/S
1.23x
PEG
0.51x
Dividend Yield
N/A
Revenue
$781.49M
Earnings
$29.83M
Gross Margin
24.6%
Operating Margin
6.53%
Profit Margin
3.8%
Debt to Equity
0.7
Operating Cash Flow
$42M
Beta
1.14
Next Earnings
Feb 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A
DCO Overview
Ducommun Incorporated designs, engineers, and builds complex electronic systems, large contoured Aerostructures (e.g., winglets, engine components, and fuselage structural panels), and many other engineered products and aftermarket services for aerospace, defense, military, and space markets. Ducommun was established in 1849 and is headquartered in Santa Ana, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DCO's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Defense
Industry Rating
C
DCO
Ranked#3 of 66
Ranked#3 of 66
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $51.79 | A | |
| $28.13 | B | |
| $8.94 | B |
Be the first to know about important DCO news, forecast changes, insider trades & much more!
DCO News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DCO ($68.26) is trading above its intrinsic value of $53.76, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DCO is poor value based on its earnings relative to its share price (33.63x), compared to the US market average (30.62x)
P/E vs Market Valuation
DCO is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more DCO due diligence checks available for Premium users.
Valuation
DCO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
33.63x
Industry
33.28x
Market
30.62x
DCO is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DCO is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
DCO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.52x
Industry
6.3x
DCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DCO price to earnings growth (PEG)
For valuing profitable companies with growth potential
DCO is good value based... subscribe to Premium to read more.
PEG Value Valuation
DCO's financial health
Profit margin
Revenue
$201.4M
Net Income
$10.1M
Profit Margin
5%
DCO's Earnings (EBIT) of $51.03M... subscribe to Premium to read more.
Interest Coverage Financials
DCO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.1B
Liabilities
$464.3M
Debt to equity
0.7
DCO's short-term assets ($570.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DCO's short-term assets ($570.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DCO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$13.9M
Investing
-$2.0M
Financing
-$4.1M
DCO's operating cash flow ($42.25M)... subscribe to Premium to read more.
Debt Coverage Financials
DCO vs Defense Stocks
Ducommun Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.